Akoya Biosciences Inc (AKYA)
3.81
-0.01
(-0.26%)
USD |
NASDAQ |
Apr 26, 16:00
3.81
0.00 (0.00%)
After-Hours: 20:00
Akoya Biosciences Total Assets (Quarterly): 180.37M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 180.37M |
September 30, 2023 | 177.24M |
June 30, 2023 | 188.88M |
March 31, 2023 | 154.30M |
December 31, 2022 | 176.03M |
September 30, 2022 | 176.46M |
June 30, 2022 | 184.26M |
Date | Value |
---|---|
March 31, 2022 | 187.13M |
December 31, 2021 | 190.91M |
September 30, 2021 | 195.41M |
June 30, 2021 | 206.34M |
March 31, 2021 | 74.48M |
December 31, 2020 | 77.66M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
74.48M
Minimum
Mar 2021
206.34M
Maximum
Jun 2021
166.88M
Average
180.37M
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
Bruker Corp | 4.250B |
Azenta Inc | 2.824B |
Harvard Bioscience Inc | 137.37M |
Bionano Genomics Inc | 214.40M |
Singular Genomics Systems Inc | 265.47M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 126.60M |
Shareholders Equity (Quarterly) | 53.77M |
Debt to Equity Ratio | 1.400 |
Current Ratio | 3.446 |
Net Debt Paydown Yield | -1.88% |